Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Molecular Cancer
Published in: Molecular Cancer 1/2012

Open Access 01-12-2012 | Research

Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K

Authors: Gui Ren, Qifei Tian, Yanxin An, Bin Feng, Yuanyuan Lu, Jie Liang, Kai Li, Yulong Shang, Yongzhan Nie, Xin Wang, Daiming Fan

Published in: Molecular Cancer | Issue 1/2012

Login to get access

Abstract

Background

Coronins are a family of highly evolutionary conserved proteins reportedly involved in the regulation of actin cytoskeletal dynamics, although only coronin 3 has been shown to be related to cancer cell migration. In glioblastoma cells, the knockdown of coronin 3 inhibits cell proliferation and invasion. Coronin 3 is also associated with the aggression and metastasis of hepatocellular carcinoma. In this paper, we analyze the migration, invasion and metastasis abilities of gastric cancer cells after up- or down-regulation of coronin 3, and explore the mechanism of coronin 3 in the process of gastric cancer metastasis.

Results

The expression of coronin 3 was higher in the highly metastatic sub-cell line MKN28-M, which we established in our laboratory. We also demonstrated that the expression of coronin 3 was remarkably higher in lymph lode metastases than in primary gastric cancer tissues, and over-expression of coronin 3 was correlated with the increased clinical stage and lymph lode metastasis. Recombinant lentiviral vectors encoding shRNAs were designed to down-regulate coronin 3 expression in gastric cancer cell lines. Stable knockdown of coronin 3 by this lentiviral vector could efficiently inhibit the migration and invasion of MKN45 gastric cancer cells. In contrast, up-regulation of coronin 3 significantly enhanced migration and invasion of MKN28-NM cells. In addition, knockdown of coronin 3 significantly reduced liver metastasis in mice after tail vein injection of gastric cancer cells. The Human Tumor Metastasis PCR Array was used to screen the metastasis-associated genes identified by the down-regulation of coronin 3, and the results suggested that, following the knockdown of coronin 3, the tumor cell migration and invasion were inhibited by the reduced expression of MMP-9 and cathepsin K.

Conclusion

Coronin 3 is highly expressed in gastric cancer metastases and can promote the metastatic behaviors of gastric cancer cells, including their migration and invasion.
Appendix
Available only for authorised users
Literature
1.
Gupta GP, Massague J: Cancer metastasis: building a framework. Cell. 2006, 127 (4): 679-695. 10.1016/j.cell.2006.11.001CrossRefPubMed
2.
3.
Yamaguchi H: Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 2005, 168 (3): 441-452. 10.1083/jcb.200407076PubMedCentralCrossRefPubMed
4.
Uetrecht AC, Bear JE: Coronins: the return of the crown. Trends Cell Biol. 2006, 16 (8): 421-426. 10.1016/j.tcb.2006.06.002CrossRefPubMed
5.
Kessels MM: Controlling actin cytoskeletal organization and dynamics during neuronal morphogenesis. Eur J Cell Biol. 2011, 90 (11): 926-933. 10.1016/j.ejcb.2010.08.011CrossRefPubMed
6.
Chan KT, Creed SJ, Bear JE: Unraveling the enigma: progress towards understanding the coronin family of actin regulators. Trends Cell Biol. 2011, 21 (8): 481-488. 10.1016/j.tcb.2011.04.004PubMedCentralCrossRefPubMed
7.
Nurnberg A, Kitzing T, Grosse R: Nucleating actin for invasion. Nat Rev Cancer. 2011, 11 (3): 177-187. 10.1038/nrc3003CrossRefPubMed
8.
Rybakin V, Clemen CS: Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking. Bio Essays. 2005, 27 (6): 625-632.
9.
Luan S-L: Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. J Pathol. 2010, 222 (2): 166-179. 10.1002/path.2752CrossRefPubMed
10.
Thal D: Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. J Pathol. 2008, 214 (4): 415-424.CrossRefPubMed
11.
Wu L: Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation. J Exp Clin Cancer Res. 2010, 29 (1): 17- 10.1186/1756-9966-29-17PubMedCentralCrossRefPubMed
12.
Spoerl Z: Oligomerization, F-actin interaction, and membrane association of the ubiquitous mammalian coronin 3 are mediated by its carboxyl terminus. J Biol Chem. 2002, 277 (50): 48858-48867. 10.1074/jbc.M205136200CrossRefPubMed
13.
14.
Duffy MJ: Proteases as prognostic markers in cancer. Clin Cancer Res. 1996, 2 (4): 613-618.PubMed
15.
Cordes C: Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival. Lung Cancer. 2009, 64 (1): 79-85. 10.1016/j.lungcan.2008.07.005CrossRefPubMed
16.
Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002, 2 (8): 563-572. 10.1038/nrc865CrossRefPubMed
17.
18.
Fernando HS, Kynaston HG, Jiang WG: WASP and WAVE proteins: Vital intrinsic regulators of cell motility and their role in cancer (Review). Int J Mol Med. 2009, 23 (2): 141-148.PubMed
19.
20.
Mullins RD, Heuser JA, Pollard TD: The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. Proc Natl Acad Sci USA. 1998, 95 (11): 6181-6186. 10.1073/pnas.95.11.6181PubMedCentralCrossRefPubMed
21.
Cai L: Coronin 1B antagonizes cortactin and remodels Arp2/3-containing actin branches in lamellipodia. Cell. 2008, 134 (5): 828-842. 10.1016/j.cell.2008.06.054PubMedCentralCrossRefPubMed
22.
Weaver AM: Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol. 2001, 11 (5): 370-3744. 10.1016/S0960-9822(01)00098-7CrossRefPubMed
23.
Rosentreter A: Coronin 3 involvement in F-actin-dependent processes at the cell cortex. Exp Cell Res. 2007, 313 (5): 878-895. 10.1016/j.yexcr.2006.12.015CrossRefPubMed
24.
Thal DR: Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. J Pathol. 2007, 214 (4): 415-424. 10.1002/path.2308.CrossRef
25.
Wu L: Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation. J Exp Clin Cancer Res. 2010, 29: 17- 10.1186/1756-9966-29-17PubMedCentralCrossRefPubMed
26.
Luan SL: Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. J Pathol. 2010, 222 (2): 166-179. 10.1002/path.2752CrossRefPubMed
27.
Sossey-Alaoui K: WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res. 2005, 308 (1): 135-145. 10.1016/j.yexcr.2005.04.011CrossRefPubMed
28.
Clark ES: Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 2007, 67 (9): 4227-4235. 10.1158/0008-5472.CAN-06-3928CrossRefPubMed
29.
30.
Nascimento CF: Role of MMP9 on invadopodia formation in cells from adenoid cystic carcinoma. Study by laser scanning confocal microscopy. Microscopy Research and Technique. 2010. Feb, 73 (2): 99-108.PubMed
31.
Sossey-Alaoui K: WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res. 2005, 308 (1): 135-145. 10.1016/j.yexcr.2005.04.011CrossRefPubMed
32.
Tie J: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010, 6 (3): e1000879- 10.1371/journal.pgen.1000879PubMedCentralCrossRefPubMed
33.
34.
Zhang F: Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: A novel cancer biomarker. Cancer Lett. 2009, 274 (2): 250-258. 10.1016/j.canlet.2008.09.031CrossRefPubMed
35.
Tang S: Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther. 2010, 9 (2): 88-95. 10.4161/cbt.9.2.10283CrossRefPubMed
36.
Jin H: p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res. 2007, 5 (5): 423-433. 10.1158/1541-7786.MCR-06-0407CrossRefPubMed
Metadata
Title
Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K
Authors
Gui Ren
Qifei Tian
Yanxin An
Bin Feng
Yuanyuan Lu
Jie Liang
Kai Li
Yulong Shang
Yongzhan Nie
Xin Wang
Daiming Fan
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2012
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-11-67

Other articles of this Issue 1/2012

Molecular Cancer 1/2012 Go to the issue

Research

The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas

Short communication

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Research

c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis

Research

Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck

Research

miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer

Research

β3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits